AEHR stock is down 9.4% in the latest session and 15% from its 52-week high because a $60 million ATM equity raise diluted shareholders just as analyst targets average $62 — but 11 analysts still rate it a Buy with that $62 average price target. The semiconductor wide-bandgap test cycle is what makes the AEHR pullback worth watching.
Key Stock Data for AEHR
| Metric | Value |
| Current Price | $86.91 |
| 52-Week Range | $8.02 – $102.48 |
| Market Cap | $2.7B |
| P/E Ratio | N/A (low TTM EPS) |
| EPS (TTM) | ~$0.20 |
| Analyst Consensus | Buy (11 Buy / 1 Hold / 0 Sell) |
| Average Price Target | $62.00 |
This deep-dive on why AEHR stock is dropping looks at the bullish and bearish analyst opinions on Aehr Test Systems, the $60M ATM equity offering that closed in April 2026, and whether the AI-processor burn-in tailwind makes the dip worth buying. The AEHR stock price has run from $8 to $102 and pulled back to $86.91 — sector-trend investors should know this is now a wide-bandgap diversification story, not a silicon-carbide one.
Table of Contents
- Key Stock Data for AEHR
- Why Is AEHR Stock Dropping? Key Takeaways
- What Is Aehr Test Systems?
- AEHR Recent Stock Performance
- Why Is AEHR Down Today?
- AEHR Valuation Analysis After the 15% Decline
- AEHR Faces Silicon Carbide Reset Amid AI Processor Pivot
- Bullish and Bearish Analyst Opinions on Aehr Test Systems
- AEHR Named Analyst Price Targets After the Decline
- AEHR Stock FAQs
Why Is AEHR Stock Dropping? Key Takeaways
- Price and verdict: AEHR at $86.91, down 9.4% in last session and 15% from $102.48 high — setup is compelling at current levels for risk-tolerant buyers.
- Key stat: Q4 2025 revenue $14.1M (-15% YoY) but FY2025 bookings $61.1M (+24% YoY) on AI-processor burn-in growth.
- Reasons for decline: $60M ATM equity offering completed April 2026, silicon-carbide revenue collapse from 90% to under 40% of mix, insider sales.
- Reasons drop is overdone: AI-processor burn-in 0% to 35% of revenue in 12 months, 11 Buy ratings, $37M+ in single-quarter bookings driven by AI/data-center demand.
- Verdict framing: The setup is compelling at current levels — 15% off the highs with a major mix-shift catalyst into AI processor testing, but the $62 average target sits below spot, so size accordingly.
What Is Aehr Test Systems?
Aehr Test Systems Inc. (NASDAQ: AEHR) designs and sells semiconductor wafer-level test and burn-in systems used by chipmakers and OEMs to ensure long-term reliability of their devices before they ship into mission-critical applications. Burn-in is the stress-test step where chips are run hot under voltage to expose infant-mortality failures, and Aehr’s WaferPak and FOX systems automate the process at the wafer level rather than the package level — saving cost and time.
The product mix is undergoing a major reset that explains why AEHR stock is dropping in the short term. In fiscal 2024, silicon carbide (SiC) wafer-level burn-in for EV power semiconductors was over 90% of revenue — a single-end-market dependency on the EV cycle. In fiscal 2025, that mix collapsed to under 40% as EV demand decelerated, while AI processor burn-in went from 0% to over 35% of revenue. That’s a textbook product-cycle pivot — but the transition leaves quarterly numbers volatile while the customer mix recomposes.
AEHR Recent Stock Performance
AEHR’s price action over the past year is a sector-trend story in microcosm. The 52-week range from $8.02 to $102.48 captures the full ride from EV-led capitulation lows to AI-driven rally highs. Year-to-date through April, AEHR is up roughly 50% even after the recent pullback. The most recent session saw a 9.4% single-day decline from $95.91 to $86.91 — a cleanly observable drop trigger that’s enough to flip the trading classification from “forecast” to “dropping.”
The recent downside is partly mechanical: completion of the $60M ATM equity offering on April 16, 2026 added supply at a time when momentum was already cooling. Director sales totaling roughly 8,787 shares (worth around $661,000) on April 21 reinforced the bearish near-term tone. Investors comparing AEHR to broader semiconductor-equipment exposure can use the LRCX stock price page as a much-larger-cap benchmark, and the AMAT stock price page as another peer for sector-trend positioning.
Why Is AEHR Down Today?
The single biggest reason AEHR stock is dropping today is supply-side dilution. On April 8, 2026, Aehr filed an at-the-market (ATM) program with William Blair and Craig-Hallum to sell up to $60 million of common stock; the program completed by mid-April. That added roughly 700,000 new shares to the float — a small absolute number but a meaningful percentage for a $2.7B-cap stock with relatively thin float and high retail concentration.
The second driver is the silicon-carbide reset. EV-power-semiconductor capex peaked in 2024 and decelerated through 2025; AEHR’s silicon carbide revenue declined from over 90% of mix to under 40%. That reset is largely complete in the model, but trailing quarters still print weakness as the AI-processor revenue ramps to fill the gap. Q4 fiscal 2025 revenue of $14.1M was -15% YoY — the kind of headline number that shakes momentum buyers.
The third driver is sentiment around analyst targets. Three Wall Street analysts publish 12-month price targets averaging $62 (range $56–$68) — meaningfully below the current $86.91 spot. Lake Street raised to $56 with a Buy, Freedom Broker raised to $61 with a Hold, Craig-Hallum sets $68. When the average target lives 30% below spot, every short-term wobble triggers re-anchoring.
AEHR Valuation Analysis After the 15% Decline
| Multiple | AEHR | Peer Avg. | Fair Ratio |
| P/E (TTM) | ~120x | 32x | — |
| P/Sales (TTM) | ~22x | 5.8x | — |
| EV/EBITDA (FY26E) | ~75x | 22x | — |
| Price vs Avg Target | +40% | — | — |
On every traditional multiple, AEHR looks rich. P/E at ~120x is roughly 4x the semiconductor-test peer median; P/Sales at ~22x is 4x peers. The dispersion is exactly why the average analyst target ($62) sits 30% below the current price ($86.91). The bull case requires you to believe AI-processor revenue ramps faster than current models assume, pushing FY27 revenue meaningfully above the $80M Wall Street is modelling.
The bull case has tangible support. AEHR booked over $37M of orders in a single quarter (calendar Q1 2026), driven by AI-processor and data-center customers. If that pace holds, FY26 bookings could clear $140M — well above the $61M booked in fiscal 2025 — which would justify a higher revenue trajectory than current consensus reflects.
AEHR Faces Silicon Carbide Reset Amid AI Processor Pivot
The structural transition story is what matters. AEHR has shifted from a single-customer, single-end-market silicon-carbide play (where the EV cycle drives everything) into a diversified test-and-burn-in supplier serving AI processors, gallium nitride power semis, data storage devices, and silicon photonics. AI processor burn-in alone went from 0% of revenue to 35%+ in fiscal 2025, and management sees that line growing materially through fiscal 2027.
The competitive moat is the WaferPak architecture — a wafer-level, parallel-test platform that can process hundreds of chips simultaneously at burn-in conditions. For AI-processor customers wrestling with cost-per-die test economics on chips that already cost $20,000+ at the wafer level, AEHR’s parallel-test approach yields meaningful savings versus traditional package-level burn-in. That cost advantage is the structural reason AI-processor demand picked up so quickly.
The bearish counter is execution risk. Test equipment is a lumpy capex business — single $5M–$15M orders create quarterly volatility that doesn’t show up in software comparables. AEHR’s bookings improved sharply in fiscal 2025, but revenue lags by roughly 6–9 months, so the visible income statement still shows the silicon-carbide air pocket. That gap is exactly why AEHR stock is dropping right now.
Customer concentration is also a risk worth flagging. Historically, two or three large silicon-carbide customers drove the bulk of AEHR’s revenue — and as those customers reduced their power-semiconductor capex through 2025, AEHR’s quarterly results compressed. The AI-processor pivot is partly addressing this concentration: the new bookings are spread across hyperscale data-center customers and merchant AI-chip designers, which structurally diversifies the customer base over the next 12–18 months. Sector-trend buyers should view this diversification as the most important multi-year change in the AEHR thesis.
Bullish and Bearish Analyst Opinions on Aehr Test Systems
| Reasons for the Decline | Reasons the Drop Is Overdone |
| $60M ATM equity offering diluted shareholders (~700K new shares) | $37M+ in single-quarter bookings show AI-processor demand is real |
| Silicon carbide revenue collapsed from 90% to under 40% of mix | 11 Buy ratings vs only 1 Hold and 0 Sell — sell-side broadly constructive |
| Q4 fiscal 2025 revenue -15% YoY pressures momentum buyers | FY2025 bookings $61.1M (+24% YoY) lead revenue by 6–9 months |
| Average analyst target $62 sits 30% below current spot $86.91 | AI processor burn-in 0% to 35% of revenue in 12 months — diversification working |
| Director sale of 8,787 shares ($661K) on April 21 added bearish tone | WaferPak parallel-test architecture remains a structural cost advantage |
AEHR Named Analyst Price Targets After the Decline
The sell-side coverage is small but constructive on a directional basis even if the price targets lag the recent rally. Eleven Buy ratings, one Hold, zero Sell. The published 12-month targets average $62, with high $68 (Craig-Hallum) and low $56 (Lake Street).
- Craig-Hallum: Buy, $68 target (high) — bull case anchored on AI processor burn-in ramp.
- Freedom Broker: Hold, $61 target — credits diversification, cautious on multiple.
- Lake Street: Buy, $56 target (low) — focuses on near-term silicon carbide reset risk.
- Roth MKM (historical Buy): reiterates wide-bandgap leadership thesis.
- Needham (historical Buy): highlights $61M FY25 bookings as a directional indicator.
Note the unusual setup: rating polarity (11 Buys / 1 Hold / 0 Sell) is bullish, but the headline price-target average sits below spot. That’s typically what happens when a small-cap rallies 100%+ in a few quarters — sell-side targets lag price by 1–2 quarters until consensus models catch up to the booking trajectory.
AEHR Stock FAQs
Why is AEHR stock dropping?
Three drivers, in order: (1) the $60M ATM equity offering completed April 16, 2026 added roughly 700K new shares; (2) silicon carbide revenue collapsed from 90%+ of mix to under 40% as the EV capex cycle decelerated; (3) Wall Street’s average price target ($62) sits 30% below the current spot ($86.91), so any wobble triggers re-anchoring. The 9.4% single-session drop is the visible symptom of all three pressures arriving at once.
Is AEHR a buy after the drop?
It depends on your time horizon and tolerance for volatility. The setup is compelling at current levels for investors who can stomach 30% drawdowns: the AI-processor burn-in pivot is real (0% to 35% of revenue in 12 months), bookings of $37M+ in a single recent quarter signal demand acceleration, and 11 Buy ratings vs 0 Sell shows sell-side broadly constructive. Short-term traders should size carefully because the spot price still trades 40% above the average analyst target.
Will AEHR stock recover?
Recovery depends on the AI-processor mix-shift translating into reported revenue. With FY2025 bookings of $61.1M (+24% YoY) and Q1 2026 single-quarter bookings of $37M+, the directional read is positive — but reported revenue typically lags bookings by 6–9 months. Investors should track the next two quarterly reports closely; consecutive YoY revenue growth would meaningfully reset the multiple debate.
What are the bullish and bearish analyst opinions on Aehr Test Systems?
Bulls (Craig-Hallum, Roth MKM, Needham) anchor on the wafer-level burn-in moat, AI-processor revenue ramp, and the FY2025 bookings reset. Bears (Lake Street’s $56 target, near-term Hold from Freedom Broker) flag the silicon-carbide air pocket, the rich P/E versus peers, and recent dilution from the $60M ATM offering. Eleven Buy ratings versus one Hold tells you sell-side is structurally constructive.
How did the $60M ATM offering affect AEHR?
The April 2026 ATM offering raised approximately $60 million through William Blair and Craig-Hallum, adding roughly 700,000 new shares to the float. For a stock with a $2.7B market cap and constrained float, that’s a small absolute number but a meaningful supply event in the short term. The capital extends operational runway and supports R&D investment in next-generation WaferPak and packaging-test platforms — but the dilution is the proximate reason why AEHR stock is dropping in late April.
Bottom line on the AEHR stock price analysis: setup is compelling at current levels for tolerant buyers, but a 40% gap above the average analyst target argues for sized exposure. The AI-processor pivot is the real catalyst — and the silicon-carbide reset is mostly priced.
Disclaimer
This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell securities. Past performance does not guarantee future results. Investors should conduct thorough due diligence and consult qualified financial advisors before making investment decisions.
MEXC is a global cryptocurrency exchange committed to “MEXCmize Your Opportunities.” Serving over 40 million users across 170+ countries, MEXC offers access to more than 3,000 digital assets across spot and derivatives markets. Known for its high liquidity and broad selection of trending tokens, the platform is designed to support both new traders and experienced investors. MEXC also continues to enhance trading efficiency through innovations such as zero trading fees, while prioritizing a secure, user-friendly, and accessible trading experience. Select MEXC as Your 0-fee Gateway To Infinite Opportunities.
